Next Generation Probiotics for Neutralizing Obesogenic Effects: Taxa Culturing Searching Strategies.

Ana López-Moreno, Inmaculada Acuña, Alfonso Torres-Sánchez, Ángel Ruiz-Moreno, Klara Cerk, Ana Rivas, Antonio Suárez, Mercedes Monteoliva-Sánchez, Margarita Aguilera

Journal: Nutrients 2021;13(5):1617

PMID: 34065873

Abstract

The combination of diet, lifestyle, and the exposure to food obesogens categorized into "microbiota disrupting chemicals" (MDC) could determine obesogenic-related dysbiosis and modify the microbiota diversity that impacts on individual health-disease balances, inducing altered pathogenesis phenotypes. Specific, complementary, and combined treatments are needed to face these altered microbial patterns and the specific misbalances triggered. In this sense, searching for next-generation beneficial microbes or next-generation probiotics (NGP) by microbiota culturing, and focusing on their demonstrated, extensive scope and well-defined functions could contribute to counteracting and repairing the effects of obesogens. Therefore, this review presents a perspective through compiling information and key strategies for directed searching and culturing of NGP that could be administered for obesity and endocrine-related dysbiosis by (i) observing the differential abundance of specific microbiota taxa in obesity-related patients and analyzing their functional roles, (ii) developing microbiota-directed strategies for culturing these taxa groups, and (iii) applying the successful compiled criteria from recent NGP clinical studies. New isolated or cultivable microorganisms from healthy gut microbiota specifically related to obesogens' neutralization effects might be used as an NGP single strain or in consortia, both presenting functions and the ability to palliate metabolic-related disorders. Identification of holistic approaches for searching and using potential NGP, key aspects, the bias, gaps, and proposals of solutions are also considered in this review.

Address: Department of Microbiology, Faculty of Pharmacy, Campus of Cartuja, University of Granada, 18071 Granada, Spain.; Center of Biomedical Research, Institute of Nutrition and Food Technology "José Mataix", University of Granada, Armilla, 18016 Granada, Spain.; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Campus of Cartuja, University of Granada, 18071 Granada, Spain.; IBS, Instituto de Investigación Biosanitaria, 18012 Granada, Spain.; Department of Nutrition and Food Science, Campus of Cartuja, University of Granada, 18071 Granada, Spain.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.